Current advancements in transdermal biosensing and targeted drug delivery

79Citations
Citations of this article
118Readers
Mendeley users who have this article in their library.

Abstract

In this manuscript, recent advancements in the area of minimally-invasive transdermal biosensing and drug delivery are reviewed. The administration of therapeutic entities through the skin is complicated by the stratum corneum layer, which serves as a barrier to entry and retards bioavailability. A variety of strategies have been adopted for the enhancement of transdermal permeation for drug delivery and biosensing of various substances. Physical techniques such as iontophoresis, reverse iontophoresis, electroporation, and microneedles offer (a) electrical amplification for transdermal sensing of biomolecules and (b) transport of amphiphilic drug molecules to the targeted site in a minimally invasive manner. Iontophoretic delivery involves the application of low currents to the skin as well as the migration of polarized and neutral molecules across it. Transdermal biosensing via microneedles has emerged as a novel approach to replace hypodermic needles. In addition, microneedles have facilitated minimally invasive detection of analytes in body fluids. This review considers recent innovations in the structure and performance of transdermal systems.

Cite

CITATION STYLE

APA

Pandey, P. C., Shukla, S., Skoog, S. A., Boehm, R. D., & Narayan, R. J. (2019, March 1). Current advancements in transdermal biosensing and targeted drug delivery. Sensors (Switzerland). MDPI AG. https://doi.org/10.3390/s19051028

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free